Telomerase levels change in OFFER study

Published: 2 August 2017| Version 1 | DOI: 10.17632/csz5rw8fyk.1
Contributors:
Tomasz Pawelczyk, Marta Grncow-Grabka, Elżbieta Trafalska, Janusz Szemraj, Natalia Żurner, Agnieszka Pawełczyk

Description

Changes in telomerase levels during 26-weeks supplementation of n-3 PUFA or placebo (olive oil) in first-episode schizophrenia patients.

Files

Categories

Psychiatry, Schizophrenia, Telomerase

Licence